Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Shares Purchased by Fourth Sail Capital LP

Fourth Sail Capital LP increased its holdings in Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) by 16.6% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 3,698,961 shares of the company's stock after buying an additional 527,859 shares during the quarter. Bioceres Crop Solutions comprises approximately 6.7% of Fourth Sail Capital LP's portfolio, making the stock its 6th biggest position. Fourth Sail Capital LP owned about 5.90% of Bioceres Crop Solutions worth $22,490,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of BIOX. Ping Capital Management Inc. increased its stake in Bioceres Crop Solutions by 7.3% in the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company's stock worth $268,000 after buying an additional 3,000 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of Bioceres Crop Solutions by 49.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company's stock valued at $708,000 after purchasing an additional 29,693 shares during the last quarter. Finally, Stifel Financial Corp grew its holdings in Bioceres Crop Solutions by 33.4% during the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company's stock valued at $321,000 after purchasing an additional 10,224 shares during the last quarter. 17.68% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on BIOX shares. Canaccord Genuity Group dropped their price target on Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Lake Street Capital decreased their target price on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating for the company in a research note on Friday, February 7th. Finally, Oppenheimer cut their price objective on Bioceres Crop Solutions from $13.00 to $12.00 and set an "outperform" rating for the company in a research report on Tuesday, January 28th. Four investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Bioceres Crop Solutions currently has an average rating of "Buy" and a consensus price target of $9.88.

Remove Ads

Bioceres Crop Solutions Trading Up 13.2 %

NASDAQ:BIOX traded up $0.58 on Thursday, hitting $4.98. The stock had a trading volume of 1,084,537 shares, compared to its average volume of 143,336. The company has a fifty day moving average price of $5.92 and a two-hundred day moving average price of $7.07. The stock has a market cap of $312.30 million, a price-to-earnings ratio of 249.12 and a beta of 0.57. The company has a quick ratio of 0.96, a current ratio of 1.33 and a debt-to-equity ratio of 0.43. Bioceres Crop Solutions Corp. has a 1-year low of $3.69 and a 1-year high of $13.50.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.